Publications
amfAR produces a variety of publications. Most are available in hard
copy and can be ordered through amfAR’s Public Information department,
120 Wall Street, 13th Floor, New York, NY 10005-3908. You may also fax
your request to (212) 806-1601 or e-mail info@amfar.org.
To download electronic copies in PDF format, click on the following
titles (unless indicated otherwise). You must have Adobe Acrobat Reader
in order to view PDF files.
- Is PEPFAR Funding for Key Populations Aligned with the Epidemiologic Burden? (Special Report, 2016)
- Following the Money to Key Populations, National Priorities, and Evidence-Based Budgeting (Special Report, 2016)
- The World Without PEPFAR (Infographic, 2016)
- The amfAR Country/Regional Operational Plan Database (2016)
- Harm Reduction and the Global HIV Epidemic (Special Report,2015)
- Hepatitis C and Drug Pricing: The Need for a Better Balance (Issue brief, 2015)
- Data Watch: Closing a Persistent Gap in the AIDS Response (Report, 2014)
- Sustaining the Global HIV Response: Innovative Financing Options (Issue brief, 2014)
- The Investment Case for Global AIDS Funding: Getting Smarter, Showing Results (Issue brief, 2014)
- Trans-Pacific Partnership: Curbing Access to Medicines Now and in the Future (Issue brief, 2015)
- An Action Agenda to End AIDS: Where are we in realizing the promise of beginning to end AIDS? (September 2013)
- Issue Brief: Tackling HIV/AIDS Among Key Populations: Essential to Achieving an AIDS-Free Generation (July 2013)
- The TREAT Asia Report
- Issue Brief: The Effect of Budget Sequestration on Global Health: Projecting the Human Impact in Fiscal Year 2013
- An Action Agenda to End AIDS Critical Actions from 2012-2016 to Begin to End the HIV/AIDS Pandemic (July 2012)
- The Investment Case for Maintaining PEPFAR Funding in FY13 (Issue Brief, April 2012)
- Estimating the human impact of global health funding in the President’s fiscal year 2013 budget proposal (Issue Brief 2012)
- TREAT Asia Report (Newsletter)
- TREAT Asia: A Cooperative Approach to Combating HIV in Asia and the Pacific
- Fact Sheet: WHO Guidelines for the Screening, Care, and Treatment of Persons with Hepatitis C Infection
Available in English, Mandarin, Indonesia Bahasa, Malay, Thai, and Vietnamese.
- Resources to Support Transition of Adolescents from Pediatric to Adult HIV Care
- HIV Treatment Clinical Brief: Dolutegravir
- HIV Treatment Snapshot: Dolutegravir
- PrEP Acceptability Among Female Sex Workers in Thailand: Key Research Findings
- Cervical Cancer, Human Papillomavirus (HPV), and HPV Vaccines in Southeast Asia (Special Report, 2016)
- Fact Sheet on WHO Guidelines for the Screening, Care, and Treatment of Persons with Hepatitis C Infection (2016)
- Hepatitis C Treatment Snapshots: Ledipasvir + Sofosbuvir (2016)
- Hepatitis C Treatment Snapshots: Daclatasvir (2016)
- Hepatitis C Treatment Snapshots: Sofosbuvir (2015)
- TAHOD-LITE: Antiretroviral Treatment for Adult HIV Infection in Asia, 1998 to 2013 (2015)
- Sexual and Reproductive Health of HIV-Positive Women in Asia (Policy Brief, 2014)
- WHO Guidelines for the Screening, Care, and Treatment of Persons with Hepatitis C Infection (Fact Sheet, 2014)
- Hepatitis C and HIV – Addressing the Dual Epidemic (Policy brief, 2014)
- Lost in Transitions: Current Issues Faced by Adolescents Living with HIV in Asia Pacific (Report, 2013)
- Ensuring Universal Access to Comprehensive HIV Services for MSM in Asia and the Pacific (Special report, 2009)
- Expanded Availability of HIV/AIDS Drugs in Asia Creates Urgent Need for Trained Doctors (Special report, 2004)
HIV/AIDS among gay men, other men who have sex with men, and transgender individuals